
“The unpredictable ABSORB” – very late stent thrombosis of bioresorbable vascular scaffold
Author(s) -
Akshyaya Pradhan,
Pravesh Vishwakarma,
Sameer Ganpat Vankar,
Rishi Sethi
Publication year - 2019
Publication title -
heart views
Language(s) - English
Resource type - Journals
eISSN - 0976-5123
pISSN - 1995-705X
DOI - 10.4103/heartviews.heartviews_18_19
Subject(s) - medicine , stent , thrombosis , lumen (anatomy) , bioresorbable scaffold , drug eluting stent , scaffold , radiology , biomedical engineering , surgery , percutaneous coronary intervention , cardiology , myocardial infarction , restenosis
Bioresorbable vascular scaffolds represent the next revolution in stent technology. They serve the dual purpose of antiproliferative drug delivery to vascular lumen like a drug-eluting stents (DES) as well as phased strut resorption over time leading to virtual elimination of stent thrombosis. The ABSORB GT-1 stent was the prototype bioresrbable vascular scaffold with maximum clinical experience and initial promising results. However, reports of stent thrombosis emerged with ABSORB too. Although the use of intracoronary imaging and proper implantation technique has the potential to reduce stent thrombosis rates, the device has been withdrawn from the market for now. We report a case of late stent thrombosis with ABSORB which was managed with DES-supported intracoronary imaging.